HLB Pharmaceutical and Neocrema Join Forces to Discover New Materials for Brain Health

[Asia Economy Reporter Kum Boryeong] HL Biopharma is teaming up with Neocrema to discover new materials for brain health.

HL Biopharma announced on the 4th that it has signed a memorandum of understanding (MOU) with Neocrema to discover new materials for brain health functional foods.

Through this agreement, HL Biopharma plans to be the first in Korea to introduce minerals that pass through the blood-brain barrier (BBB) and help improve memory and cognitive function, and develop mass production technology for brain health functional foods. Neocrema is a domestic food material company that supplies functional food ingredients and food additives such as probiotics and functional protein materials.

HL Biopharma explained, "The ingredient was developed by researchers at the Massachusetts Institute of Technology (MIT) in the United States," adding, "Clinical research in the U.S. confirmed that the overall cognitive ability of adults with cognitive impairment improved. Global health functional food companies use this mineral as a key ingredient in products aimed at cognitive improvement."

HL Biopharma and Neocrema will jointly conduct tasks such as forming a consultative body for joint research, performing product commercialization and related tasks, cooperating on intellectual property applications under joint names for related results, and jointly carrying out technology support projects based on the secured products and technologies through this business agreement.

Park Jaehyung, CEO of HL Biopharma, said, "We plan to register this mineral as an individually recognized ingredient next year," adding, "By combining Neocrema's specialized material technology and HL Biopharma's new drug development capabilities specialized in degenerative brain diseases, we will create world-class products that improve cognitive function."

This content was produced with the assistance of AI translation services.